Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | Greenstreet Yvonne | 87.7K | $30.05M | -9,577 |
| CEO | | 66.2K | $22.69M | - |
| CFO | Poulton Jeffrey V. | 60.2K | $20.61M | -2,780 |
| CFO | | 54.2K | $18.58M | - |
| VP | | 33.4K | $11.44M | - |
Transactions
50 transactions · page 20
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2017-02-01 | SHARP PHILIP A | Director | Sale+OE | 25,000 | $39.80 | $995,124.76 | -8.0% | → |
| 2017-01-25 | SHARP PHILIP A | Director | Sale+OE | 15,000 | $37.95 | $569,250.00 | -9.6% | → |
| 2017-01-18 | SHARP PHILIP A | Director | Sale+OE | 15,000 | $37.83 | $567,456.00 | -5.0% | → |
| 2016-12-01 | Greene Barry E | President | Sale+OE | 31,825 | $42.99 | $1,368,127.63 | -10.1% | → |
| 2016-11-30 | Vaishnaw Akshay | EVP, R&D, CMO | Sale+OE | 29,165 | $44.99 | $1,311,997.85 | -46.5% | → |
| 2016-10-13 | PYOTT DAVID E I | Director | Buy | 27,900 | $37.00 | $1,032,327.90 | New | → |
| 2016-07-20 | MARAGANORE JOHN | CEO | Sale+OE | 30,151 | $64.69 | $1,950,590.03 | -4.2% | → |
| 2016-04-20 | MARAGANORE JOHN | Chief Executive Officer | Sale+OE | 30,151 | $67.46 | $2,033,972.21 | -4.3% | → |
| 2016-03-09 | BONNEY MICHAEL W | Director | Buy | 2,000 | $58.36 | $116,720.00 | +100.0% | → |
| 2016-02-23 | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | 1,000,000 | $7.18 | $7,180,000.00 | -17.0% | → |
| 2016-02-22 | Gros David-Alexandre C | SVP, Chief Business Officer | Buy | 1,000 | $62.75 | $62,749.00 | +1,000% | → |
| 2016-01-20 | MARAGANORE JOHN | Chief Executive Officer | Sale+OE | 30,152 | $71.78 | $2,164,218.65 | -1.3% | → |
| 2015-12-04 | SHARP PHILIP A | Director | Sale+OE | 30,000 | $109.00 | $3,270,000.00 | -17.6% | → |
| 2015-12-02 | MARAGANORE JOHN | Chief Executive Officer | Sale+OE | 58,689 | $104.87 | $6,154,715.34 | -7.1% | → |
| 2015-11-20 | MARAGANORE JOHN | Chief Executive Officer | Sale+OE | 27,137 | $102.34 | $2,777,078.46 | -14.1% | → |